ACTIVATION OF STAT1 BY MUTANT FIBROBLAST GROWTH-FACTOR RECEPTOR IN THANATOPHORIC DYSPLASIA TYPE-II DWARFISM

Citation
Wcs. Su et al., ACTIVATION OF STAT1 BY MUTANT FIBROBLAST GROWTH-FACTOR RECEPTOR IN THANATOPHORIC DYSPLASIA TYPE-II DWARFISM, Nature, 386(6622), 1997, pp. 288-292
Citations number
30
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Multidisciplinary Sciences
Journal title
NatureACNP
ISSN journal
0028-0836
Volume
386
Issue
6622
Year of publication
1997
Pages
288 - 292
Database
ISI
SICI code
0028-0836(1997)386:6622<288:AOSBMF>2.0.ZU;2-F
Abstract
The achondroplasia class of chondrodysplasias comprises the most commo n genetic forms of dwarfism in humans and includes achondroplasia, hyp ochondroplasia and thanatophoric dysplasia types I and II (TDI and TDI I), which are caused by different mutations in a fibroblast growth-fac tor receptor FGFR3 (ref, 1), The molecular mechanism and the mediators of these FGFR3-related growth abnormalities are not known, Here we sh ow that mutant TDII FGFR3 has a constitutive tyrosine kinase activity which can specifically activate the transcription factor Stat1 (for si gnal transducer and activator of transcription)(2,3). Furthermore, exp ression of TDII FGFR3 induced nuclear translocation of Stat1, expressi on of the cell-cycle inhibitor p21(WAF1/CIP1), and growth arrest of th e cell. Thus, TDII FGFR3 may use Stat1 as a mediator of growth retarda tion in bone development, Consistent with this, Stat1 activation and i ncreased p21(WAF1/CIP1) expression was found in the cartilage cells fr om the TDII fetus, but not in those from the normal fetus, Thus, abnor mal STAT activation and p21(WAF1/CIP1) expression by the TDII mutant r eceptor may be responsible for this FGFR3-related bone disease.